Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain

Area of Science:

• Pharmacology
• Neuroscience
• Diabetology

Background:

• Syzygium cumini (Jamun) is traditionally used in India for diabetes mellitus treatment.
• Diabetic complications often involve oxidative stress and tissue damage, particularly in the brain.
• Alloxan-induced diabetic rats are a common model for studying diabetes and its effects.

Purpose of the Study:

• To investigate the neuroprotective effects of Jamun seed extracts in diabetic rats.
• To compare the efficacy of aqueous and alcoholic Jamun seed extracts against diabetes-induced brain damage.
• To evaluate the extracts against a standard anti-diabetic drug, glibenclamide.

Main Methods:

• Oral administration of aqueous and alcoholic Jamun seed extracts (JSEt) to alloxan-induced diabetic rats for 6 weeks.
• Measurement of lipid levels, thiobarbituric acid reactive substances (TBARS) as a marker of lipid peroxidation, and antioxidant enzymes (catalase, superoxide dismutase) in the brain.
• Comparison of extract efficacy with glibenclamide.

Main Results:

• Aqueous JSEt significantly decreased lipids and TBARS while increasing catalase and superoxide dismutase in diabetic rat brains.
• Alcoholic JSEt normalized these parameters to near-normal levels.
• Both aqueous and alcoholic JSEt demonstrated superior effects compared to glibenclamide, with the alcoholic extract being more potent.

Conclusions:

• Syzygium cumini seed extracts possess significant antioxidant and neuroprotective properties.
• The extracts effectively mitigate diabetes-induced tissue damage in the rat brain.
• Jamun seed extracts represent a potential therapeutic agent for managing diabetic complications.